Chiusura precedente | 10,29 |
Aperto | 10,27 |
Denaro | N/D x N/D |
Domanda | N/D x N/D |
Min-Max giorno | 10,24 - 10,30 |
Intervallo di 52 settimane | 9,09 - 11,86 |
Volume | |
Media Volume | 4.286.611 |
Capitalizzazione | N/D |
Beta (mensile su 5 anni) | 0,17 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | 24 ott 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
9 October 2023 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at leas
Press releaseParis, 26 September 2023 Enovacom, Orange Business’ healthcare subsidiary, strengthens its leadership in e-health with the acquisition of NEHS Digital and Xperis The acquisitions of NEHS Digital and Xperis reinforce Orange Business’ strategy of developing solutions for healthcare professionalsEnovacom is a leading French player in interoperability, telemedicine and now, with these acquisitions, in medical imaging Today Enovacom, the French leader for healthcare data interoperability